Is an NSAID simply any anti-inflammatory drug which does not have a
steroid core?  Or must there explicitly be some Cox activity?

As a group of scientists (I am a chemist) in the technical patent
industry, we are trying to clarify our NSAID definition.  I assumed
that as long as the anti-inflammatory agent was not a steroid, it was
an NSAID.  Somebody else thought there needed to be an additional
requirement (i.e. that the molecule also be labeled a Cox inhibitor.)
Thanks,

Dayton